- Men posing as cops break into home of former deputy
- Berkshire County eschews greenback for own currency — BerkShares
- Hagel warns Pakistani leaders of U.S. aid losses over drone-strike protests
- Florida authorities ban autistic boy from owning therapeutic chickens
- Defendant in Lee Rigby machete murder trial: ‘I love al Qaeda’
- Obama lied about Syrian chemical attack, ‘cherry-picked’ intelligence: report
- MSNBC host: Obamacare a ‘wealthy white men’ racist word
- Democrat thwarts Nevada activist’s try to name peak after Reagan
- Congress ready to extend ban on plastic firearms
- Rogue reindeer runs from Santa, eludes police for hours
By Brahma Chellaney
Beijing's creeping aggression signals a challenge to U.S. presence in the Asian Pacific
Independent voices from the The Washington Times Communities
Topic - Jules Hirsch
New research powerfully strengthens the case against soda and other sugary drinks as culprits in the obesity epidemic.
A weight-loss drug that was expected to be a blockbuster failed to gain approval yesterday from a key advisory committee to the Food and Drug Administration because it appears to increase the risk of suicidal tendencies.
"There is a reasonable suspicion we better learn some more and watch this affair more closely before we launch into massive use of this drug," said panelist Dr. Jules Hirsch, of the Rockefeller University.